Article
Perspectives on Medicare’s Proposed iDose TR Coverage Policy
In May 2026, 5 Medicare Administrative Contractors released proposed Local Coverage Determinations (LCDs) addressing Medicare reimbursement for anterior-segment intraocular nonbiodegradable drug-eluting systems, a category that currently includes only the travoprost intracameral implant iDose TR (Glaukos). Glaucoma Physician spoke with several leading surgeons who expressed concerns about the proposed LCDs and suggested changes they believe would better reflect contemporary glaucoma practice.







